We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » No Federal Hurdles to Barr's Adderall IR Launch
No Federal Hurdles to Barr's Adderall IR Launch
October 3, 2006
Barr Pharmaceutical announced Sept. 28 that it is now free to close a deal with Shire, acquiring the rights to Shire’s attention-deficit/
hyperactivity disorder drug Adderall immediate-release (IR) tablets.